The initial public offering (IPO) of Emcure Pharmaceuticals got off to a lukewarm start on July 3rd, the first day of bidding. Here’s a breakdown of the subscription data. Overall Subscription Ratio: 0.29 times, meaning bids were received for only 29% of the shares offered. Non-institutional Investors: Most active category, […]